Skip to main content
Premium Trial:

Request an Annual Quote

New Products from Illumina, CombiMatrix

Premium

Illumina last week launched two Infinium genotyping products for customers performing whole-genome and focused-content SNP genotyping.

The company said its HumanHap550+ BeadChip product allows customers to add up to 120,000 custom SNP markers to supplement the standard content provided on the firm's HumanHap550 BeadChip. In total, the two chips yield approximately 670,000 markers for association studies, Illumina said.

Illumina's iSelect Infinium product enables customers to create a custom array of up to 60,000 SNP markers per sample with 12 samples per chip, the company said. The custom genotyping technology is offered as a product or a service.



CombiMatrix last week introduced its QuadroCAS CustomArray Synthesizer. Co-developed with Japanese life sciences company Furuno Electric, CMBX said that the QuadroCAS system can fabricate up to four in situ arrays simultaneously in 24 hours or less.

The synthesizer also incorporates all reagents and hardware into a stand alone instrument, including Furuno's instrument control and signal processing electronics.

CombiMatrix will market and sell the product through its direct channels, distributor channels, and other partners and CMBX has global distribution rights for QuadroCAS, according to Mike Tognotti, CMBX's vice president of sales and marketing.

Tognotti told BioArray News this week that the QuadroCAS offers "smaller run batch sizes, low- to medium-density array formats, on-board reagents, and a smaller footprint" compared to the firm's CustomArray Synthesizer, which is "geared for customers needing higher production throughput, low, medium and high density array formats."

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.